Michael J. Fox Foundation
Other
Active
New York, United States
68
10M
58
2.83
19
0.15
13
- Stages of investment
- Areas of investment
Summary
In 2000 was created Michael J. Fox Foundation, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the New York.
Among the most successful fund investment fields, there are Health Diagnostics, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Inflazome, Ceregene.
This organization was formed by Deborah Brooks.
The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. Considering the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Michael J. Fox Foundation works on 0 percentage points less the average amount of lead investments.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Michael J. Fox Foundation, startups are often financed by MPM Capital, Third Rock Ventures, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Wellcome Trust, Agentschap NL. In the next rounds fund is usually obtained by Seventure Partners, Janke Dittmer, INKEF Capital.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 68
- Lead investments
- 19
- Exits
- 13
- Rounds per year
- 2.83
- Follow on index
- 0.15
- Investments by industry
- Biotechnology (54)
- Health Care (37)
- Therapeutics (23)
- Pharmaceutical (22)
- Medical (15) Show 28 more
- Investments by region
-
- Canada (2)
- United States (39)
- Germany (1)
- Denmark (4)
- Switzerland (6) Show 7 more
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 76M
- Group Appearance index
- 0.04
- Avg. company exit year
- 2
- Avg. multiplicator
- 2.49
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Sapiens Steering Brain Stimulation | 28 Nov 2011 | Health Care, Medical, Therapeutics, Simulation | Early Stage Venture | 11M | Munich, Bavaria, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.